Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 224 | -433 | 408 | 180 | 178 |
| Depreciation Amortization | 161 | 768 | 580 | 393 | 196 |
| Accounts receivable | -429 | -184 | -492 | -332 | -286 |
| Accounts payable and accrued liabilities | 60 | -36 | 3 | -91 | 38 |
| Other Working Capital | -467 | 308 | 204 | 449 | -289 |
| Other Operating Activity | 369 | 1,154 | 489 | 423 | 248 |
| Operating Cash Flow | $-82 | $1,577 | $1,192 | $1,022 | $85 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -243 | -194 | -147 | -65 |
| Other Investing Activity | -83 | -278 | 0 | 0 | 0 |
| Investing Cash Flow | $-83 | $-521 | $-194 | $-147 | $-65 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 20 | 20 | 9 | 9 |
| Financing Cash Flow | $N/A | $20 | $20 | $9 | $9 |
| Beginning Cash Position | 1,596 | 520 | 520 | 520 | 520 |
| End Cash Position | 1,431 | 1,596 | 1,538 | 1,404 | 549 |
| Net Cash Flow | $-165 | $1,076 | $1,018 | $884 | $29 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82 | 1,577 | 1,192 | 1,022 | 85 |
| Capital Expenditure | N/A | -243 | -194 | -147 | -65 |
| Free Cash Flow | -82 | 1,334 | 998 | 875 | 20 |